양막 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)

Amniotic Membrane Market size was valued at USD 5.18 Billion in 2024 and is poised to grow from USD 5.96 Billion in 2025 to USD 18.37 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The amniotic membrane (AM) is gaining traction in the healthcare market, particularly among ophthalmology and orthopedic specialists, due to its efficacy in treating various conditions and enhancing surgical outcomes. The rising patient population with related diseases drives the demand for innovative amniotic membrane products, allowing for more efficient surgical interventions. The growing inclination for tissue-based solutions in ophthalmic surgeries significantly contributes to market expansion, as these products promote quicker patient recovery. Additionally, the increasing popularity of aesthetic surgical procedures is expected to further fuel market growth. Technological advancements, including cryopreservation, bioengineering, and the development of biocompatible scaffolds, are enhancing the functionality of amniotic membranes, thereby improving tissue repair and regeneration capabilities, which aligns with the evolving needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Amniotic Membrane market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Amniotic Membrane Market Segments Analysis

Global Amniotic Membrane Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane. Based on Application, the market is segmented into Surgical Wounds, Ophthalmology and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research Institutes and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Amniotic Membrane Market

The rising incidence of severe injuries among workers engaged in fieldwork is significantly driving the demand for swift and efficient healing therapies. Traumatic injuries, particularly among children and young adults, are predominantly caused by road accidents, which continue to be a pressing issue. With road safety concerns escalating and traffic congestion intensifying globally, the frequency of accidents is increasing. This surge in trauma cases directly contributes to the growth of the amniotic membrane market, as healthcare providers seek advanced solutions to facilitate recovery and healing for those affected by such injuries. As a result, the market for amniotic membranes is flourishing.

Restraints in the Amniotic Membrane Market

The amniotic membrane market faces significant challenges due to the high costs associated with producing these specialized products and their related services. The manufacturing of amniotic membrane products necessitates intricate biological processing and techniques that are essential for preserving their natural properties while ensuring safety. Maintaining stringent quality control, conducting thorough testing, and adhering to regulatory standards are crucial aspects of this production process, which collectively contribute to elevated expenses. As a result, the financial burden can create obstacles for patients, suppliers, and healthcare systems, potentially limiting access and adoption of these valuable therapies.

Market Trends of the Amniotic Membrane Market

The amniotic membrane market is witnessing significant growth driven by favorable healthcare policies in emerging economies, particularly in Asia-Pacific nations like China, India, and Brazil. These regions boast improved healthcare infrastructure, reduced regulatory barriers, and an expanding patient population. Additionally, increasing healthcare expenditures and pro-business governance create a conducive environment for market players. The burgeoning demand for innovative wound care and surgical applications, combined with a competitive landscape spurred by global players focusing on these emerging markets, further enhances market prospects. As awareness of the therapeutic benefits of amniotic membranes rises, investment opportunities in these regions are set to intensify.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Amniotic Membrane Market Size by Product & CAGR (2026-2033)

• Market Overview
• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane

Global Amniotic Membrane Market Size by Application & CAGR (2026-2033)

• Market Overview
• Surgical Wounds
• Ophthalmology
• Others

Global Amniotic Membrane Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes and Academic Institutes

Global Amniotic Membrane Market Size & CAGR (2026-2033)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• MiMedx Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTissue Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amnio Technology, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Biologics LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celularity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skye Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Regenerative Technologies, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Katena Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech Inc. (BioTissue) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amniox Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire CCD. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVEX Biologics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merakris Therapeutics. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allosure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations